• [Low Fat, Aisle 2: Grocer to Flag Healthful Foods]

    Grocer to Flag Healthful Foods

    Supervalu is rolling out a storewide nutritional information program, the first national grocery chain to label which products on its shelves meet government health recommendations.

  • Subscriber Content Read Preview

    J&J Wins Stent Ruling

    Johnson & Johnson won another round in a long-running patent case over heart stents, making it more likely that Boston Scientific will pay its rival $700 million.

  • Subscriber Content Read Preview

    Lilly Reaches Zyprexa Settlement

    Eli Lilly agreed to pay $1.42 billion in a settlement with federal prosecutors regarding allegations of improperly marketing its antipsychotic drug Zyprexa.

  • Subscriber Content Read Preview

    Genentech Has Strong Quarter

    Genentech's fourth-quarter profit rose 47% as the biotechnology firm recorded strong sales for most of its U.S. products.

  • Subscriber Content Read Preview

    Roche Plans to Cut 780 Jobs

    Swiss drug maker Roche plans to cut 780 production jobs over the next two to three years, warning that the pharmaceutical industry won't be immune to the effects of a worsening economic environment.

  • Paying Relatives to Look After Elderly

    Caring for a family member is a responsibility many people bear. It can also be a source of income.

  • [Tom Daschle before the Senate panel considering his nomination, Jan. 8.]

    Daschle Confirmation Has Slowed

    GOP aides on the Senate finance panel are examining Daschle's tax records and links to an education-loan firm.

  • [Peanut-Butter Probe Focuses on Georgia Plant]

    Peanut Probe Focuses on Georgia Plant

    Safety inspectors are focusing on a peanut-processing plant in Georgia as the possible source of a salmonella outbreak that has sickened at least 425 people and may have caused five deaths.

  • House Passes Kids' Health-Care Bill

    The House voted to expand government-sponsored health care to 4 million more children as Democrats tried to give Obama an early win on health care.

  • Heart Risks Seen in Antipsychotic Drugs

    Patients taking the latest generation of antipsychotic drugs are twice as likely to suffer sudden cardiac failure as nonusers, according to a new study.

  • Subscriber Content Read Preview

    [Glaxo's Emails on Avandia Reveal Concern]

    Glaxo's Avandia Emails Reveal Concern

    Glaxo's internal emails indicate the company's own data was reflecting a study, which linked its diabetes treatment Avandia to heart-attack risk.

  • FDA Starts Pilot Program for Drug Safety

    The FDA launched a voluntary pilot program to promote the safety of drugs and active drug ingredients produced outside the U.S.

  • Subscriber Content Read Preview

    [pfizer plans job cuts]

    Pfizer to Lay Off Researchers

    Pfizer is laying off up to 800 researchers as the pharmaceutical industry faces pressure to cut spending.

  • Subscriber Content Read Preview

    [Walgreen Broadens Health-Care Reach]

    Walgreen Broadens Health-Care Reach

    Walgreen plans to announce a network of pharmacies, clinics and health centers it will market to employers.

Health Blog

Series: Nonprofit Hospitals

Latest Health Headlines

From Dow Jones Newswires

Columns

More Industries

Subscriber Content

  • Journal Community

    The doctors and the insurers put up obstacles or rules to keep my understanding of the system to a minimum and just as I figure out my way around the obstacle course, they change the rules again!

    —Catherine Morris

Research Health

View an interactive map that shows you how stocks in the Healthcare sector are doing today, at a glance.

Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.

Dow Jones Industry Tracker - Healthcare

Answer a Question

Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question.

Q: What do you think is the main reason why healthcare isn't affordable to all?

More questions:
Partner Center
An Advertising Feature
SPECIAL ADVERTISING FEATURES

Inside the Wall Street Journal Digital Network